13 December 2018 Local Site to Support Global Product Demand KREMS, Austria, December 13, 2018 - Merck Animal Health (known as MSD Animal Health outside the US and Canada), a division of Merck & Co., Inc., Kenilworth, N.J., USA, today announced two significant milestones in its continued effort to expand manufacturing capacity and capabilities at its large-scale, vaccine production facility with product formulation and filling capabilities in Krems, Austria. The site, which is expected to be fully operational in 2023, recently received the Government Manufacturer`s Authorization and the Certificate of Good Manufacturing Practices (GMP) of a Manufacturer, which will allow the company to begin...
|
